step-wedge randomization. However, 46% of participants in the intervention group were noncompliant with blood glucose lowering medication when recommended. This will likely not improve with a step-wedge randomization. How do the authors plan to improve this? Is it possible to improve this? 8. As a primary outcome, caesarean section is not a very good outcome, as it depends how many women had previous caesarean sections. Those women would likely have repeat caesarean sections regardless of the intervention.
REVIEWER
Michelle Downie Southern District Health Board New Zealand REVIEW RETURNED 20-Aug-2017
GENERAL COMMENTS
This is an ongoing important piece of work which aims to provide evidence as to the best course of management in women with a 'pre diabetes' level HbA1c at booking. This work will be of international interest as at present there is no high quality evidence to answer this question. This feasibility study has provided important insights for planning the future trial. There was a high rate of protocol no adherence in both study groups. The authors have correctly identified this may have been related to the patient information sheet to some degree, and will be able to modify this going forward before the main trial. However there was apparent issues with acceptability of allocated treatment in both groups , which also warrants consideration going forward. The proposal of a cluster step -wedge design for the main trial may eliminate some of these problems. The high rates of protocol breach and non adherence to allocated treatment, as well as the small sample size, makes it invalid in my opinion to draw any conclusion form the outcome data. I therefore think it is inappropriate to state in the conclusion that the results "suggest there may be more adverse pregnancy outcomes associate with standard care". While this may indeed be the case, this conclusion cannot be drawn from the presented data. The conclusion should focus on what has been learnt from the feasibility study, rather than inferring meaning to the outcomes. Recruitment was less than expected leading the authors to extend the gestational age at recruitment. There is understandable concern that going forward if women are enrolled too close to the 24 week mark this may skew results and dilute the effect of early intervention. However, this feasibility study reflects real world experience which shows in reality many women are not presenting for booking until later, especially Maori and Pasifika women which the authors have correctly identified as being a sub group of special interest and concern. Perhaps in the main study, there could be two different groups for analysis such as women enrolled before 14-16 weeks gestation and women enrolled between 14-24 weeks as again I think this would be very helpful information for clinicians responsible for these women. Although documented in the table, I would like to see a short description of the main outcomes of interest in the results section of the paper, particularly the outcomes of rates of C section, pre eclampsia and neonatal hypoglycaemia. I think this warrants description and not just reference to the table. It would also be worth mentioning that there was a very high rate of Asian women in the population -approximately 50%. This is higher then the background demographic of the population and I would be interested in the authors interpretation of this. On page 5, line 25 'randomise' should be 'randomised' I believe. Overall I support this being published as it will be of significant interest to those involved in looking after women with an elevated HbA1c in this range at booking. At the moment there is significant controversy about the optimal strategy and I very much look forward to seeing the results of the main trial. 
REVIEWER

GENERAL COMMENTS
In this study authors test the feasibility of a two-arm parallel randomised control trial of standard care versus early intervention in pregnancies complicated by prediabetes.
Comments
• Which was the rationale to include information regarding women who refused to participate?
• It should be discussed the possible ethical issues compromised about it.
• There is contradictory information about the proportion of Māori and Pacific women that declined to participate as is stated in text (page 11) and Table 1 • P value in Tables is mandatory • How can influence on the results of study the low frequency of Māori and Pacific women enrolled?
• Difference of Hb at booking <110 g/L between women in the early intervention and control groups, should be discussed.
• How can influence in the results the elevated frequency (9%) of women with history of GDM in the control group?
• The repetitive statement of study's aim in the first paragraph of Discussion section is unnecessary • Limitation of study should be discussed in detail • Manuscript should be shortened
VERSION 1 -AUTHOR RESPONSE
Cover letter BMJ Open 8th December 2017 Dear EDITOR IN CHIEF Dr Trish Groves, Thank you for considering our manuscript entitled 'Prediabetes in pregnancy, can early intervention improve outcomes? A feasibility study for a parallel randomised clinical trial' for consideration for publication in BMJ Open. Our responses to the editor and referees' comments are below. Editorial Requirements: -CONSORT checklist is included.
-We have revised the Strengths and Limitations section to focus on the methodologi cal strengths and limitations of your study rather than summarizing the results.
Reviewer: 1 1. In the abstract, under Results: first sentence: "which also biased against participation by Maori and Pacifica women". What biased against their participation? This is unclear from the sentence.
-the abstract has been revised to include "Recruitment rates were lower than expected, especially in Māori and Pacific women." We later discuss in the results and the discussion the reasons behind this.
2. Page 6, under Intervention, second sentence: "were offered 3-6 weekly outpatient visits throughout pregnancy", Does this mean every week for 3 to 6 weeks? Or 3-6 visits throughout the rest of pregnancy, but not weekly? -we have clarified the sentence "The early intervention group were offered outpatient visits every 3-6 weeks…"
3. Page 8, perinatal death: do you mean birth weight <400g? not >400g -it is correct as written, clarified now to "or at a birth weight of ≥400g…."
4. Under Results: first paragraph, last line: "We do not know if other potentially eligible women were not referred to clinic". This would be important to know in order to know whether lower referrals occurred due to an over-estimation of the numbers of women with prediabetes, or because t he caregivers just didn't refer them or the caregivers didn't measure the HbA1c. Could do an audit to assess this.
-we have deleted this sentence and have since calculated that 80% of potentially eligible women were referred -this is now included in the discussion. "We predicted that ~2-4% of the birthing population would be eligible, whereas since the conclusion of this study, prospective laboratory data from Auckland suggest that only ~1.2% of the birthing population were eligible. Only 0.9% of the birthing population (~80% of potential recruits) were referred."
5. With the lower HbA1c assay, can you determine what the percentage of prediabetes patients one can expect if all women were referred? -please see point 4 above.
6. How did extending the recruitment to <16 weeks improve recruitment and retention as stated on page 9? Or to <20 weeks in Christchurch site? Were there women that were eligible but were only referred after 14 weeks or 20 weeks? -we have extended a sentence in the results section to include "..which improved recruitment and retention rates by capturing women who booked later in pregnancy and the late/delayed referrals." 7. Non-compliance was high in this cohort. I agree that some of the non-compliance and contamination will improve with the suggested step-wedge randomization. However, 46% of participants in the intervention group were noncompliant with blood glucose lowering medication when recommended. This will likely not improve with a step-wedge randomization. How do the authors plan to improve this? Is it possible to improve this? -we have changed a paragraph in the discussion to address your points. "A high proportion of participants did not adhere to the assigned intervention. Noncompliance with blood glucose monitoring may be less likely if randomisation is by site rather than at the individual level as participant compliance may be more likely when driven by clinic protocol rather than being influenced by a study information sheet stating that both treatment options may be equally effective. Compliance with medication is likely to be somewhat of an issue for both arms of the study irrespective of study design, highlighting the importance of positive relationships between patients and healthcare workers and adequate patient education and follow-up."
8. As a primary outcome, caesarean section is not a very good outcome, as it depends how many women had previous caesarean sections. Those women would likely have repeat caesarean sections regardless of the intervention.
-we agree and have added further information on caesarean section in table 2 and changed the wording in the first and last paragraph of the discussion to include the word emergency.
Reviewer: 2
The high rates of protocol breach and non adherence to allocated treatment, as well as the small sample size, makes it invalid in my opinion to draw any conclusion form the outcome data. I therefore think it is inappropriate to state in the conclusion that the results "suggest there may be more adverse pregnancy outcomes associate with standard care". While this may indeed be the case, this conclusion cannot be drawn from the presented data. The conclusion should focus on what has been learnt from the feasibility study, rather than inferring meaning to the outcomes.
-We agree with the reviewers comments and have deleted that sentence from the conclusion and moved text down from the discussion to read "A future definitive study exploring standard care versus early intervention, in pregnant women without known pre-existing diabetes and with a HbA1c ≥5.9-6.4% (41-46mmol/mol) measured at booking, is likely to be feasible with modifications to the study design. We propose a cluster step-wedge randomised study design across ten sites in NZ. Randomisation by site rather than at the individual level would help reduce both the ethnic disparity in recruitment and the 'contamination' rate between the two intervention arms of the study." -We have also reworded the text relating to outcomes in the abstract and results secti on so that we do not overstate what was shown.
Perhaps in the main study, there could be two different groups for analysis such as women enrolled before 14-16 weeks gestation and women enrolled between 14-24 weeks as again I think this would be very helpful information for clinicians responsible for these women.
-We have altered the discussion to include "An option for a definitive trial would be to extend the gestation of eligibility and perform subgroup analysis of outcomes by gestation at recruitment ."
Although documented in the table, I would like to see a short description of the main outcomes of interest in the results section of the paper, particularly the outcomes of rates of C section, pre eclampsia and neonatal hypoglycaemia.
-We did not wish to focus on the clinical outcomes too much given that they were not our outcome measures and we were not powered to look at them. We have altered the statistical section of the methods to read: "Baseline characteristics and pregnancy outcomes of randomised and nonrandomised participants were summarised descriptively, but as this was a feasibility study inferential statistics (confidence intervals and p-values) testing the efficacy of treatment are not reported." -We have reworded the sentence relating to pregnancy outcomes in the abstract to read "Caesarean section and preeclampsia were signalled as potential primary outcomes, due to both the high observed incidence in the control group and ease of measurement" -We have changed the results section to read "Pregnancy outcomes of potential interest as outcome measures for a larger definitive study are described in table 2. Preeclampsia and emergency caesarean section are both clinically relevant outcomes that were easy to measure across centres and they occurred at a reasonable frequency to be considered as primary outcomes. Preterm birth and customised birth weight were both easy to measure, but neither occurred at a higher frequency than expected." -We have changed the discussion section to read "Both preeclampsia and caesarean section are clinically relevant outcomes that impact significantly on maternal and neonatal morbidity and on health care costs.
[15] The emergency caesarean section rate in the control arm of this study was higher than our national total caesarean section rate in NZ (<20%). Logically, early intervention versus intervention commencing at 24 weeks gestation is more likely to improve outcomes related to placentation, such as preeclampsia and preterm birth, whist both interventions m ay improve outcomes related to fetal hyperinsulinemia, such as macrosomia and neonatal hypoglycaemia."
It would also be worth mentioning that there was a very high rate of Asian women in the populationapproximately 50%. This is higher then the background demographic of the population and I would be interested in the authors interpretation of this.
-The sentence "Non-European women in NZ have a higher rate of prediabetes [12]…" is included in the discussion. Asian women do make up a high proportion of our women with GDM in both Christchurch and Auckland.
On page 5, line 25 'randomise' should be 'randomised' I believe.
-Thank you, this has been changed Reviewer: 3
Comments
• Which was the rationale to include information regarding women who refused to participate? It should be discussed the possible ethical issues compromised about it.
-We have included this sentence in the discussion "We assessed the characteristics of women who declined to participate to see if we captured a representative cohort of our population, as we want the results of a definitive study to be generalisable across NZ."
-We have ethical approval and this sentence has been added to the methods section "Ethical approval was also granted to collect data from the hospital records of those who declined to participate."
• There is contradictory information about the proportion of Māori and Pacific women that declined to participate as is stated in text (page 11) and Table 1 -The information is not contradictory, but the % in the table are read by column and not by row and we have reformatted the table with the aim of clarifying this.
• P value in Tables is mandatory -Our statistician disagrees with this point since the data in the tables are purely descriptive and are not the outcome measures of the study. The feasibility study was not powered to look at these outcomes and we do not want to infer potentially incorrectly that there are no differences between groups when there might be in an adequately powered definitive study. We wanted to look at these outcomes to explore them as potential primary outcome measures in a definitive study. We hope that the changes in the text of the statistical analysis section clarifies this: "Baseline characteristics and pregnancy outcomes of randomised and non-randomised participants were summarised descriptively, but as this was a feasibility study inferential statistics (confidence intervals and p-values) testing the efficacy of treatment are not reported."
• How can influence on the results of study the low frequency of Māori and Pacific women enrolled? -We have included the following sentence in the discussion to clarify why including these women in the study is important in NZ "Recruitment rates were particularly low in Māori and Pacific women. We assessed the characteristics of women who declined to participate to see if we captured a representative cohort of our population, as we want the results of a definitive study to be generalisable across NZ. Non-European women in NZ have a higher rate of prediabetes [12] and Māori and Pacific women in particular have a greater risk of adverse pregnancy outcomes, thus they may benefit the most from early intervention"
• Difference of Hb at booking <110 g/L between women in the early intervention and control groups, should be discussed. How can influence in the results the elevated frequency (9%) of women with history of GDM in the control group? -This 'imbalance' is a risk in any randomised study, and for a definitive trial clinically important variables that are likely to influence the outcome would usually be adjusted for in a sensitivity analysis (regardless of 'balance' or not). We have added this sentence to the discussion "The low numbers meant that the control and intervention arms were not fully balanced, but as the outcome measures of this study were related to feasibility and not to clinical outcomes the mismatch was less important."
• The repetitive statement of study's aim in the first paragraph of Discussion section is unnecessary -This has been shortened.
• Limitation of study should be discussed in detail -We have re-written the discussion to highlight these points. "The strength of this study is that it was conducted across two geographically distant centres in NZ and thus the feasibility of conducting a multicentre study and recruiting in ethnically diverse populations were assessed. The major limitation was the low recruitment rate, providing fewer data for interpretation that in turn could incorrectly guide us in planning a future definitive trail. The low numbers meant that some covariates were not well balanced between the treatment groups, but as the outcome measures of this study were related to feasibility and not to clinical outcomes the mismatch was less important. Although we conclude that the protocol of this feasibility study was not suitable for a definitive trial, we do not know with certainty that our recommend protocol changes (below) are feasible."
• Manuscript should be shortened -We have edited the document reorganising some areas and deleting repetitive statements and unnecessary wording.
Yours sincerely, Ruth Hughes, Janet Rowan and Jonathan Williman
